Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer: final analysis of the randomized RATIONALE-315 trial

作者：Chong Wang, Yang Wang, Hongrui Liu, Qi Chen, Chao Chen, Hong Li, Peng Zhang, Guohua Zhao, Fan Yang, Guorong Han, Bentong Yu, Yue Yang, Hao Chen, Jie Jiang, Lijie Tan, Shuangbing Xu, Ning Mao, Jian Hu, Li Zhang, Zhigang Zhang, Bo Yao, Shuxiao Wang, Shiang Jiin Leaw, K. Naicker, Wenxin Zheng, Changyuan Yu, Dongsheng Yue · 发表于：Annals of Oncology · 年份：2025 · DOI：10.1016/j.annonc.2025.11.017 · 被引用次数：7 · 研究领域：Cancer Immunotherapy and Biomarkers、Lung Cancer Diagnosis and Treatment、Lung Cancer Treatments and Mutations